Professor Christopher Hyde
Professor of Public Health and Clinical Epidemiology
Chris Hyde was recruited to Exeter in 2009. He is a School lead for research on test evaluation including systematic reviews, economic models and primary research. He leads the Exeter Test Group and is the diagnostics theme lead for PenCLAHRC. He is part of the Peninsula Technology Assessment Group (PenTAG). He directed the team delivering health technology assessments for national policy-making bodies, particularly NICE, from 2009 until 2015 and continues to support it by being the lead on HTAs of tests and through membership of its steering group. He is a long standing member of NICE's Diagnositc Advisory Committee and recently joined the National Screening Committee.
Chris qualified in medicine in 1986 and worked in general medicine until 1990. He then undertook specialist training in Public Health, completing this in 1996. In 1994 he did a placement at the UK Cochrane Centre as part of his specialist training and became interested in using research to inform decisions about health. In 1996 he set up and directed a unit based in the University of Birmingham to support commissioners of health care use research (ARIF) which continued until 2012. He became progressively more active in doing research as well as disseminating it and became Director of the West Midlands Health Technology Assessment Collaboration (WMHTAC) in 2007. He was also closely involved in setting up the NHS Blood & Transplant Systematic Reviews Initiative and has contributed to the work of the Cochrane Collaboration since its inception.
Throughout his career Chris has been variously intrigued and frustrated by research on tests and their interpretation. He has done many systematic reviews and health economic models on a wide variety tests including near patient tests in primary care, novel methods of processing cervical smears, hysteroscopy, tests for predicting preeclampsia and preterm birth, PET/CT scanning for breast cancer and OSNA for sentinel lymph node biopsy in breast cancer. A recurring theme is that test evaluations are often not fit for purpose and provide only indirect evidence about whether a new test will benefit patients and society if introduced. Helping to improve this situation is the main purpose of Chris’s research at UEMS.
Broad research specialisms
- Systematic reviews and meta-analysis
- Health economic modelling
- Health technology assessment
- Test evaluation
- Research dissemination
- Health policy making
- MB BS (St Thomas’s Hospital, London)
|Tel||+44 (0) 1392 726051|
University of Exeter
St Luke's Campus